Markets:

Overview

News

Currencies

International

Treasuries

ZyVersa Therapeutics, Inc. - Common Stock (NQ:ZVSA)

0.3113 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ZyVersa Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

ZyVersa Therapeutics Announces Equity Research Coverage Initiated by Noble Capital Markets

January 04, 2024

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics CEO, Stephen C. Glover, Issues Letter to Shareholders Providing Outlook for 2024

January 03, 2024

From ZyVersa Therapeutics

Via GlobeNewswire

This Biotech Is Targeting Indications Worth $70 Billion ↗

December 22, 2023

Stephen C. Glover, Co-founder, Chairman, CEO and President of ZyVersa Therapeutics Inc. (NASDAQ: ZVSA) was recently a guest on Benzinga’s All-Access.

Via Benzinga

Why ZyVersa Therapeutics Shares Are Down 40% ↗

December 07, 2023

ZyVersa Therapeutics Inc (NASDAQ: ZVSA) shares are trading lower by 43.7% to $1.20 Thursday morning.

Via Benzinga

Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 19, 2023

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy...

Via Benzinga

Why Motus GI Holdings Shares Are Trading Lower By Around 46%; Here Are 20 Stocks Moving Premarket ↗

December 19, 2023

Shares of Motus GI Holdings, Inc. (NASDAQ: MOTS) shares fell sharply in pre-market trading after the company priced its $5 million public offering. Motus GI Holdings shares dipped 46.5% to $1.15 in...

Via Benzinga

ZyVersa Therapeutics’ CEO, Stephen C. Glover, to Participate in BIO Partnering @ JPM During “J.P. Morgan Week 2024”

December 18, 2023

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics Engages CRO, George Clinical, for Phase 2a Clinical Trial for Cholesterol Efflux Mediator VAR 200

December 14, 2023

From ZyVersa Therapeutics

Via GlobeNewswire

Dow Surges 100 Points; Ciena Posts Upbeat Earnings ↗

December 07, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Thursday. The Dow traded up 0.28% to 36,155 while the NASDAQ rose 1.41% to 14,346.47. The S&P...

Via Benzinga

Topics Stocks

Gold Moves Lower; Dollar General Earnings Beat Estimates ↗

December 07, 2023

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.06% to 36,077.32 while the NASDAQ rose 1.09% to 14,301.04....

Via Benzinga

Topics Earnings Stocks

ZyVersa Therapeutics Announces Publication Demonstrating That Plasma Levels of NLRP3 Inflammasomes Correlate with Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes

December 07, 2023

From ZyVersa Therapeutics

Via GlobeNewswire

Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 07, 2023

Shares of Methode Electronics, Inc (NYSE: MEI) fell sharply during Thursday’s session following weak quarterly earnings.

Via Benzinga

Nasdaq Jumps Over 100 Points; US Jobless Claims Edge Higher ↗

December 07, 2023

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.04% to 36,068.53 while the...

Via Benzinga

Topics Stocks

Rivian (RIVN) Stock Just Scored a New ‘Buy’ Rating ↗

December 07, 2023

Rivian stock is gaining on Thursday after Stifel weighed in on RIVN shares with a buy rating and set a price target of $25 per share.

Via InvestorPlace

Why Is ZyVersa Therapeutics (ZVSA) Stock Down 44% Today? ↗

December 07, 2023

ZyVersa Therapeutics stock is falling hard on Thursday after the company priced a public offering for shares of ZVSA this morning.

Via InvestorPlace

Why Cerevel Therapeutics Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

December 07, 2023

Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) jumped in pre-market trading after AbbVie Inc. (NYSE: ABBV) announced it will acquire the company for a total equity value of approximately...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 07, 2023

It's time to start off Thursday with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning!

Via InvestorPlace

ZyVersa Therapeutics, Inc. Announces Pricing of $5.0 Million Public Offering

December 06, 2023

From ZyVersa Therapeutics

Via GlobeNewswire

Shopify (SHOP) Stock Falls Following Analyst Downgrade ↗

December 06, 2023

Shopify stock is taking a beating on Wednesday after shares of SHOP were hit with a downgrade from Wedbush analyst Scott Devitt.

Via InvestorPlace

Why Is Pharvaris (PHVS) Stock Up 36% Today? ↗

December 06, 2023

Pharvaris stock is rising higher on Wednesday following news of an underwritten offering for PHVS shares and pre-funded warrants.

Via InvestorPlace

Why Is ZyVersa Therapeutics (ZVSA) Stock Up 27% Today? ↗

December 06, 2023

ZyVersa Therapeutics stock is rising with heavy trading of ZVSA shares after a paper was published in a peer-reviewed journal.

Via InvestorPlace

ZyVersa Therapeutics Announces Publication Showing AIM2 and NLRP3 Inflammasomes Promote Atherosclerosis in Diabetes, Supporting IC 100’s Rationale for Targeting ASC to Inhibit Multiple Inflammasome Pathways

December 06, 2023

From ZyVersa Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 30, 2023

Via Benzinga

ZyVersa Therapeutics, Inc. Announces Reverse Stock Split and Increase in Authorized Shares of Common Stock

November 30, 2023

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics Reports Third Quarter 2023 Corporate Update and Financial Results

November 14, 2023

From ZyVersa Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 14, 2023

Via Benzinga

Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

November 13, 2023

Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 13, 2023

Via Benzinga

US Stocks Fall; Tyson Foods Posts Upbeat Earnings ↗

November 13, 2023

U.S. stocks traded lower this morning, with the Nasdaq Composite falling around 100 points on Monday. Following the market opening Monday, the Dow traded down 0.08% to 34,254.53 while the NASDAQ fell...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 13, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.